NCT01306084

Viral Infections in Healthy and Immunocompromised Hosts

RecruitingOBSERVATIONAL

Trial Details

Start: 2011-03-15

Enrollment target: 1,000 participants

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Contact

Genital Herpes

The purpose of this study is to generate safety and immunogenicity data and establish a proof-of-concept of clinical ben…

Birmingham, United StatesCompleted Apr 25, 2025

Recurrent Genital Herpes Simplex Type 2

This study is designed to assess safety, tolerability, and pharmacokinetics (PK) of single ascending dose (SAD) of ABI-5…

Darlinghurst, AustraliaCompleted Feb 3, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.